Authors
Latest:
Individualized Beta-Lactam Therapy and MonitoringElevated beta-lactam concentrations have been associated with neurotoxic adverse effects, including seizures and mental status changes.
Latest:
Estimating HIV Screening Incidence Among US CitizensInvestigators used national electronic health record data to determine the proportion of American adults who have been tested for HIV.
Latest:
Coffee, Donuts, and Antimicrobial StewardshipTargeting stewardship interventions to the morning hours may have a greater impact than afternoons and nights.
Latest:
Systematic Review Highlights Hydroxychloroquine AmbiguitiesInvestigators sought to summarize evidence about the benefits and harms of hydroxychloroquine and chloroquine as treatments or prophylaxis of COVID-19.
Latest:
Guidelines to Caring for Patients With Sepsis: Promise or Progress?Care continues to improve; however, drug-resistant pathogens and a lack of new agents to treat these infections remain a constant challenge.
Latest:
Key Takeaways on Managing ABSSSIGeorge Sakoulas, MD, shares key takeaways on soft tissue infections from ID week 2023.
Latest:
Teva Pharmaceuticals Announces Launch of Generic HIV DrugTeva Pharmaceuticals announces an exclusive launch of a generic version of atazanavir capsules for the treatment of HIV.
Latest:
Entering the Ring: Oral Vancomycin Versus Metronidazole for C difficile Infection and the Risk of Vancomycin-Resistant EnterococcusIn 2017, a guideline update stripped metronidazole of its first-line therapy designation and crowned oral vancomycin as initial therapy for all C difficile infection cases.
Latest:
Integrating Order Sets Into Antimicrobial Stewardship StrategiesSince its implementation in December 2016, use of a ceftolozane-tazobactam order set at Marin General Hospital has advanced antimicrobial stewardship efforts.
Latest:
Final Thoughts on COVID-19 and FluFinal thoughts from experts on controlling COVID-19 and influenza.
Latest:
Rapid ART Initiation: A New Model Presents Unique Opportunities and ChallengesPatients with a new diagnosis of HIV may benefit from rapid start of ART.
Latest:
Long-Acting Anti-MRSA Agents: One Dose to Cure?A review of the current literature and future directions.
Latest:
A Case of CNS Nocardia farcinica Presenting as Aphasia in an Immunocompetent HostQuick recognition is key to early initiation of treatment and long-term survival.
Latest:
Utilizing MRSA Nasal Screening for Antimicrobial StewardshipThis In the Literature piece details a study evaluating MRSA nasal screening’s effect on antimicrobial stewardship.
Latest:
Continuing the Fight Against Gram-Negative Infections: What's in the Pipeline—Part 3Part 3 of our series looks at
Latest:
A New Meaning to "Getting Tested"Over-the-counter diagnostic tests for Chlamydia trachomatis, Neisseria gonorrhoeae, and pathogens associated with upper respiratory tract infections such as influenza and Group A Streptococcus may soon gain approval; however, making these tests immediately available to the public would not be without challenges.
Latest:
An Unexpected Meningitis CulpritA team of physicians yields surprising findings in an elderly patient in shock with seizures.
Latest:
The Future of Health Care After COVID-19My hope is that years from now, when we look back on the coronavirus disease 2019 (COVID-19) pandemic, it will have served a few purposes.
Latest:
Neglect of Skin Wounds Is a Risk Factor for Becoming a Carrier of S. AureusA new study in BMC Public Health finds that neglect of skin wounds is an independent and strong risk factor for becoming a carrier of Staphylococcus aureus (S. aureus), a dangerous pathogen that can cause infections and lead to life-threatening infectious diseases.
Latest:
The Great Debate: Polymyxin B Versus Polymyxin EAs we await novel compounds from a relatively apathetic industry, we are resurrecting antibiotics of which we have an outdated understanding. and that carry the potential for substantial side effects: polymyxins.
Latest:
Inhaled Amikacin Reduces Risk of Ventilator-Associated PneumoniaAmikacin inhaled once daily for 3 days reduced risk of developing ventilator-associated pneumonia in placebo-controlled trial in critically ill.
Latest:
Future of Fluoroquinolones: Risks, Benefits of Antibiotic WorkhorseWarnings and concerns regarding fluoroquinolones are on the rise, but the antibiotics still play a role, albeit more limited, in the treatment of various infectious diseases.
Latest:
Final Thoughts on COVID-19 and FluFinal thoughts from experts on controlling COVID-19 and influenza.
Latest:
Eosinophils, Fevers, and Diarrhea With a Surprise Diagnosis in a Patient With AIDSWhen the CD4 count seems too good to be true.
Latest:
Addressing ART Adherence in Hispanic/Latino Men Living with HIVInvestigators found these populations are younger and are living at or below poverty were at lower adherence to ART.
Latest:
A Long-Term Care Antimicrobial Stewardship Certificate Program for Pharmacists: Filling an Unmet NeedThis training will empower pharmacists practicing in LTC facilities to develop antimicrobial stewardship programs, improve patient outcomes related to infectious diseases, and facilitate compliance with CMS requirements.
Latest:
Testing Still Needed After HCV Clears in HIV-Positive MSMA retrospective study found hepatitis C reinfection rates high are in HIV-positive men who have sex with men from four western European countries.
Latest:
Lefamulin: An Overview of a Lonely SoldierLefamulin, a recently approved pleuromutilin, adds to the current antibiotic armamentarium, although its place in therapy remains to be seen.
Latest:
IDWeek 2019 News Network: Assessing Challenges to Treating CABPThomas Lodise, PharmD, PhD, provides an overview of options for treating community-acquired bacterial pneumonia and highlights the challenges of the infection.
